Wed 16 Sep 2026 International edition
♥ Support Us
Precision Medicine Executive Overview
Clinical Trials & Research Regulatory Roadblock: FDA Places Clinical Hold on REGENXBIO’s RGX-121 Gene Therapy for Hunter Syndrome Following Asymptomatic Spine Findings
Hematology & Blood Research Decoding Resistance: Precision Oncology Confronts Adaptive Vulnerabilities in Aggressive Cutaneous T-Cell Lymphomas
Laboratory Medicine Decoding the Titans of the Cosmos: How Ultraheavy Particles are Rewriting Modern Astrophysics
Laboratory Medicine Capturing the Genesis of Extreme States: Researchers Unveil Femtosecond-Scale Plasma Dynamics in Breakthrough Experiment
Hematology & Blood Research Matched comparison of therapeutic DLI and second allogeneic transplantation after relapse of acute leukemia or MDS
Biochemistry & Metabolomics Beyond Man’s Best Friend: How Co-Evolution, Climate, and Culture Forged the 15,000-Year Bond Between Humans and Dogs
Medical Devices & Lab Automation Arterex Tecate Expands Footprint with New 9,000-Square-Foot ISO Class 8 Clean Room Facility to Meet Surge in MedTech Demand
Molecular Biology & Genomics Cultivating Resilience: How Naturally Occurring Soil Microbes Offer a Breakthrough Against Global Agricultural Salinity
Healthcare Quality & Safety Bridging the Gap: Are Global Health PhD Programs Failing to Produce Transformational Leaders?
Pathology & Histology Executive Overview: A New Paradigm in Computational Pathology
Clinical Trials & Research PepGen Advances PGN-EDODM1 to Maximum Planned Dose in Phase II FREEDOM2-DM1 Trial Following Favorable Safety Review

Section 1

Section 2

Section 3

Section 4

Archive

Tag: targeting